...
首页> 外文期刊>International Urology and Nephrology >Radiocontrast-induced nephrotoxicity and urinary alpha-glutathione S-transferase levels: effect of amlodipine administration.
【24h】

Radiocontrast-induced nephrotoxicity and urinary alpha-glutathione S-transferase levels: effect of amlodipine administration.

机译:放射性对比剂引起的肾毒性和尿中的α-谷胱甘肽S-转移酶水平:氨氯地平给药的作用。

获取原文
获取原文并翻译 | 示例
           

摘要

AIMS: The exact pathogenesis and prophylaxis concerning radiocontrast-induced nephrotoxicity (RCIN) was unclear. Short-acting calcium antagonists were used to prevent RCIN. This study was designed to evaluate the role of a long-acting calcium antagonist (amlodipine) administration by determining serum creatinine (SCre) levels and 24 hour urinary excretion rates of glutathione S-transferase alpha (GST-alpha) which has a selective localization only to proximal tubular epithelium. METHODS: In a prospective trial, 29 outpatients (19 M, 10 F) undergoing coronary angiography were randomized and either amlodipine 10 mg/day (n = 15) or placebo (n = 14) were administered prior to angiography and continued thereafter. All patients had normal basal renal function and none of them had any risk factor for RCIN. A low osmolar, nonionic contrast media (iopamidol 76%) was administered to all patients. Creatinine clearance (CCre), SCre and 24-hour urinary GST-alpha levels were measured before, 24 hours and 7 days afterangiography. RESULTS: SCre and 24 hour urinary GST-alpha values increased on 24th hour following the angiography in both groups (p < 0.017 and 0.001, respectively). Pretreatment with amlodipine created no difference in both variables (p > 0.05). CONCLUSIONS: A reversible tubular dysfunction occurs following radiocontrast administration which was manifested by an increase in urinary GST-alpha excretion rates. Pretreatment with a long acting calcium antagonist amlodipine has no effect on the course of enzyme excretion and alteration observed in SCre.
机译:目的:目前尚不清楚确切的发病机制和有关放射性造影剂肾毒性(RCIN)的预防。使用短效钙拮抗剂来预防RCIN。本研究旨在通过确定仅具有选择性定位作用的谷胱甘肽S-转移酶α(GST-alpha)的血清肌酐(SCre)水平和24小时尿排泄率来评估长效钙拮抗剂(氨氯地平)的作用到近端肾小管上皮。方法:在一项前瞻性试验中,将29例接受冠状动脉造影的门诊患者(19 M,10 F)随机分组,并在进行血管造影之前给予氨氯地平10 mg /天(n = 15)或安慰剂(n = 14),然后继续进行。所有患者的基础肾功能均正常,均无RCIN危险因素。对所有患者均使用低渗透压的非离子型造影剂(碘帕醇76%)。在血管造影术前,24小时和7天后测量肌酐清除率(CCre),SCre和24小时尿GST-α水平。结果:两组血管造影后第24小时,SCre和24小时尿GST-α值均升高(分别为p <0.017和0.001)。氨氯地平预处理在两个变量上均无差异(p> 0.05)。结论:放射性造影剂给药后发生可逆性肾小管功能障碍,表现为尿GST-α排泄率增加。用长效钙拮抗剂氨氯地平预处理对SCre中观察到的酶排泄和改变过程没有影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号